The whole truth

Safety first: New EU pharmaceutical compliance will tighten up safety within the supply chain and eliminate falsified medicines

more »


Social listening in healthcare: is it irresponsible?

There’s a quietly emerging niche in the healthcare industry: social listening for marketable data. But is it moral? And is it safe? more »

Oct 7, 2014 Editor's Blog

Reddy made

Dr. Reddy's Custom Pharmaceutical Services (CPS) explains the integration of highly potent drug substance and drug product manufacturing. more »

Oct 3, 2014 Guest Blogs

Keep it clean

Andrew Barrow of Cherwell Laboratories offers an insight into monitoring cleanrooms and reducing contamination risk. more »

Sep 30, 2014 Guest Blogs

GSK in China: time to crack down on Big Pharma?

Online editor Dave Gray looks back on the conclusion of GSK's turbulence in China, and asks what impact this will have on pharma trading around the world. more »

Sep 26, 2014 Editor's Blog

Mergers - how do we benefit?

Stephen Archer of Spring Partnerships looks back on months of M&A buzz in the pharma community, and examines whether the industry really stands to benefit from corporate buyouts. more »

Sep 25, 2014 Guest Blogs

Future medicines need new thinking, says RPS


Pharmaceutical scientist are calling for a new covenant to be developed between the industry and wider society

Built with Metro Publisher™